- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06543888
Effects of Passive Lower-limb Exoskeleton-assisted Training on Motor and Daily Function Improvements in Older Adults
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Ching-Yi WU, ScD
- Phone Number: 5761 +886-3-2118800
- Email: cywu@mail.cgu.edu.tw
Study Contact Backup
- Name: Yen-Wei Chen, PhD
- Phone Number: 48053 +886-4-23323456
- Email: ywc213@asia.edu.tw
Study Locations
-
-
Guishan
-
Taoyuan, Guishan, Taiwan, 333
- Recruiting
- Chang Gung Memotial Hospital
-
Contact:
- Ching-Yi WU, ScD
- Phone Number: 5761 +886-3-2118800
- Email: cywu@mail.cgu.edu.tw
-
Principal Investigator:
- Yen-Wei Chen,, PhD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- age ≧ 60
- normal functional range of motion (within functional limits) in trunk, and leg joints
- ability to walk continuously for 10 minutes with or without an assistive device
- Mini Mental State Exam (MMSE) score > 24, indicating no serious cognitive impairment
Exclusion Criteria:
- histories of neurological diseases such as dementia, Parkinson's disease, and peripheral polyneuropathy
- recent lower leg injury (6 months) or surgery (1 year) based on self-report
- taking any over-the-counter drugs, prescription medications, or any substance that may affect gait
- difficulties in following and understanding instructions
- enroll in other rehabilitation or drug studies simultaneously -
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: passive exoskeleton- assisted gait training programs
Behavioral: passive exoskeleton- assisted gait training programs Participants will receive 12 sessions of passive exoskeleton-assisted gait training programs (30 min/session, 3 sessions/week for 4 consecutive weeks).
|
Participants will wear an exoskeleton during the training.
Each 30-minute Passive exoskeleton-assisted gait training session include range of motion exercise, movement facilitation, strengthening exercise, coordination exercise, and task-oriented training for activities of daily living
|
|
Active Comparator: conventional gait training programs
Participants will receive 12 sessions of conventional gait training programs (30 min/session, 3 sessions/week for 4 consecutive weeks).
|
Each 30-minute conventional gait training session include range of motion exercise, movement facilitation, strengthening exercise, coordination exercise, and task-oriented training for activities of daily living.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change scores of Five Times Sit to Stand Test (FTSST)
Time Frame: Baseline, post test after completing 12 intervention sessions (around 4 weeks after baseline), follow up test (1 month after completing intervention sessions)]
|
The FTSST measures the time taken to stand five times from a sitting position as fast as possible, which is used to assess functional lower limb strength, balance control, and mobility in both healthy adults and those with pathologies.
The FTSST has been proven to be safe and to have excellent reliability.
|
Baseline, post test after completing 12 intervention sessions (around 4 weeks after baseline), follow up test (1 month after completing intervention sessions)]
|
|
Change scores of Timed Up and Go Test (TUG)
Time Frame: Baseline, post test after completing 12 intervention sessions (around 4 weeks after baseline), follow up test (1 month after completing intervention sessions)]
|
The TUG test assesses dynamic balance ability and mobility.
The participants will be required to stand up from a chair, walk 3 m, turn around, walk back to the chair, and sit down.
Three trials will be taken at each assessment, and the average of three trials will be documented.
The time to complete the TUG test has been shown to be a good indicator to detect potential fallers in frail elderly individuals.
The TUG is a reliable, valid, and easy-to-administer clinical tool.
|
Baseline, post test after completing 12 intervention sessions (around 4 weeks after baseline), follow up test (1 month after completing intervention sessions)]
|
|
Change scores of 10-meter walk test (10MWT)
Time Frame: Baseline, post test after completing 12 intervention sessions (around 4 weeks after baseline), follow up test (1 month after completing intervention sessions)]
|
The 10MWT assesses walking speed in self-selected pace and fast walking pace, which can be employed to determine functional mobility. Two trials are administered at the participant's comfortable walking speed, followed by 2 trials at his/her fast walking speed. The 2 trials, for each speed, are averaged and the 2 gait speeds are documented in meters/second. The 10-meter walk test has demonstrated excellent reliability for comfortable and fastest gait speeds in healthy adults and other pathological populations. |
Baseline, post test after completing 12 intervention sessions (around 4 weeks after baseline), follow up test (1 month after completing intervention sessions)]
|
|
Change scores of Nottingham Extended Activities of Daily Living Scale (NEADL)
Time Frame: Baseline, post test after completing 12 intervention sessions (around 4 weeks after baseline), follow up test (1 month after completing intervention sessions)]
|
The NEADL is a measure of independence in 4 areas of daily life, including mobility, kitchen, domestic, and leisure activities.
It includes 22 items, and each item is measured on a 4-point scale.
The total score ranges from 0 to 66 and a higher score indicates better daily functional ability.
The psychometric properties of the NEADL have been well established.
|
Baseline, post test after completing 12 intervention sessions (around 4 weeks after baseline), follow up test (1 month after completing intervention sessions)]
|
|
Change scores of Daily Living Self-Efficacy Scale (DLSES)
Time Frame: Baseline, post test after completing 12 intervention sessions (around 4 weeks after baseline), follow up test (1 month after completing intervention sessions)]
|
The DLSES measures self-efficacy of daily functioning, including psychosocial functioning and activities of daily living.
The scale consists of 12 items, and each item is measured on a 100-point scale with 10-unit intervals (0 = cannot do at all, 100 = highly certain can do).
A higher score indicates higher level of self-efficacy.
The DLSES is a psychometrically sound measure of self-efficacy in stroke survivors.
|
Baseline, post test after completing 12 intervention sessions (around 4 weeks after baseline), follow up test (1 month after completing intervention sessions)]
|
|
Change scores of Functional Abilities Confidence Scale (FACS)
Time Frame: Baseline, post test after completing 12 intervention sessions (around 4 weeks after baseline), follow up test (1 month after completing intervention sessions)]
|
The FACS measures the degree of self-efficacy and confidence when the participants perform various movements and postures.
It consists of 15 questions scoring from 0% (not confidence at all) to 100% (fully confidence).
A higher score indicates higher confidence of performing the movements.
The psychometric properties are good.
|
Baseline, post test after completing 12 intervention sessions (around 4 weeks after baseline), follow up test (1 month after completing intervention sessions)]
|
|
Change scores of Mini-Mental State Examination (MMSE)
Time Frame: Baseline, post test after completing 12 intervention sessions (around 4 weeks after baseline), follow up test (1 month after completing intervention sessions)]
|
The MMSE a 30-point questionnaire that is the most commonly used brief screening tool for detecting cognitive impairment.
Higher values represent a better cognitive functioning.
The MMSE has good psychometric properties for identifying cognitive impairment.
|
Baseline, post test after completing 12 intervention sessions (around 4 weeks after baseline), follow up test (1 month after completing intervention sessions)]
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 202302129B0
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.